Recent discoveries indicate a distinct role for PD-L1 in modulating epithelial-to-mesenchymal transition (EMT), the cancer stem cell (CSC)-like phenotype, metastasis, and resistance to therapy [79,96]. This evidence concerns the gene CD274 and cancer.